The clinicopathological characteristics of 'triple-negative' epithelial ovarian cancer.

BACKGROUND 'Triple-negative' is traditionally used to define a specific subtype of breast cancer with negative oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-type 2 (HER2) expressions. ER/PR and HER2 testing is also widely used in the informative classification of ovarian cancer. AIM To investigate whether a… CONTINUE READING